Modeling excess lung cancer risk among screened arm participants in the mayo lung project

Cancer

Volumn 116, Issue 1, 2010, Pages 122-131

  Goldwasser, Deborah L ^a,b   Kimmel, Marek ^a,c  

^a Rice University   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Lung cancer screening; Mathematical model; Mayo Lung Project; Simulation

Indexed keywords

ADULT; ARTICLE; BAYES THEOREM; CALIBRATION; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GROUPS BY AGE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SIMULATION; THORAX RADIOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LIKELIHOOD FUNCTIONS; LUNG NEOPLASMS; MATHEMATICS; MODELS, BIOLOGICAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 74549182646     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24722     Document Type: Article

References (37)

1. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study. Am Rev Respir Dis. 1984;130:561-565.
2. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller E, Muhm JR. Lung cancer screening: the Mayo Program. J Occup Med. 1986;28:746-750.
3. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308-1316.
4. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006;98:748-756.
5. Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd edition). Chest. 2007;132:69S-77S.
6. Humphrey LL, Teutsch S, Johnson MS. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the US Preventive Services Task Force. Ann Intern Med. 2004;140:740-753.
7. Black WC. Overdiagnosis: an under-recognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000;92:1280-1282.
8. Reich JM. Improved survival and higher mortality: the conundrum of lung cancer screening. Chest. 2002;122:329-337.
9. Colby TV, Tazelaar HD, Travis WD, Bergstralh EJ, Jett JR. A pathologic review of the Mayo Lung Project. Cancer. 2002;95:2361-2365.
10. Flehinger BJ, Kimmel M, Polyak T, Melamed MR. Screening for lung cancer: the Mayo Lung Project revisited. Cancer. 1993;72:1573-1580.
11. Gorlova OY, Kimmel M, Henschke C. Modeling of long-term screening for lung carcinoma. Cancer. 2001;92:1531-1540.
12. Miettinen OS. Screening for lung cancer: do we need randomized trials? Cancer. 2000;89(suppl):2449-2452.
13. Patz EF. Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project. J Natl Cancer Inst. 2006;98:724-725.
14. Moolgavkar SH, Knudson AG. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 1981;66:1037-1052.
15. Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' follow-up studies using a multistage carcinogenesis model. Cancer Causes Control. 2008;19:317-328.
16. Little MP, Heidenreich WF, Moolgavkar SH, Schollnberger H, Thomas DC. Systems biological and mechanistic modeling of radiation-induced cancer. Radiat Environ Biophys. 2008;47:39-47.
17. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer. 2003;38:302-306.
18. Armitage P, Doll R. A 2-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957;11:161-169.
19. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology. 2004;231:440-445.
20. Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic x-rays: estimates for the UK and 14 other countries. Lancet. 2004;363:345-351.
21. Diederich S, Lenzen H. Radiation exposure associated with imaging of the chest: comparison of different radiographic and computed tomography techniques. Cancer. 2000;89(suppl):2457-2460.
22. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81:362-378.
23. Flehinger BJ, Melamed MR, Heelan RT, et al. Accuracy of chest film screening by technologists in the New York Early Lung Cancer Detection Program. AJR Am J Roentgenol. 1978;131:593-597.
24. Brenner DJ, Sachs RK. Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach. Radiat Environ Biophys. 2006;44:252-256.
25. Kai M, Luebeck EG, Moolgavkar SH. Analysis of the incidence of solid cancer among atomic bomb survivors using a 2-stage model of carcinogenesis. Radiat Res. 1997;148:348-358.
26. Heidenreich WF, Jacob P, Paretzke HG. Exact solutions of the clonal expansion model and their application to the incidence of solid tumors of atomic bomb survivors. Radiat Environ Biophys. 1997;36:45-58.
27. Pierce DA, Mendelsohn ML. A model for radiation-related cancer suggested by atomic bomb survivor data. Radiat Res. 1999;152:642-654.
28. Pierce DA, Sharp GB, Mabuchi K. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat Res. 2003;159:511-520.
29. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 1994;137:S17-S67.
30. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168:1-64.
31. Heidenreich WF, Cullings HM, Funamoto S, Paretzke HG. Promoting action of radiation in the atomic bomb survivor carcinogenesis data? Radiat Res. 2007;168: 750-756.
32. Jacob V, Jacob P. Modelling of carcinogenesis and low-dose hypersensitivity. An application to lung cancer incidence among atomic bomb survivors. Radiat Environ Biophys. 2004;42:265-273.
33. Ford MB, Sigurdson AJ, Petrulis ES, et al. Effect of smoking and radiotherapy on lung carcinoma in breast cancer survivors. Cancer. 2003;98:1457-1464.
34. Neugut AI, Murray T, Santos J, et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer. 1994;73:1615-1620.
35. Gilbert ES, Stovall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res. 2003;159:161-173.
36. Thompson JR. Simulation: A Modeler's Approach. New York, NY: John Wiley & Sons; 2000.
37. Marcus PM, Prorok PC. Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification. J Med Screen. 1999;6:47-49.